These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10852664)

  • 21. Towards 2001: will ACE inhibitors have a role in atherosclerosis treatment?
    Sharpe N
    Int J Clin Pract Suppl; 1998 May; 94():26-31. PubMed ID: 9926442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
    Fox K; Ferrari R; Yusuf S; Borer JS
    Eur Heart J; 2006 Sep; 27(18):2154-7. PubMed ID: 16905555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function.
    Poelzl G; Frick M; Lackner B; Huegel H; Alber HF; Mair J; Herold M; Schwarzacher SP; Pachinger O; Weidinger F
    Int J Cardiol; 2006 Mar; 108(1):48-54. PubMed ID: 16516697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for benefits of perindopril in hypertension and its complications.
    Laurent S
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes.
    Cheetham C; O'Driscoll G; Stanton K; Taylor R; Green D
    Clin Sci (Lond); 2001 Jan; 100(1):13-7. PubMed ID: 11115412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.
    Swislocki AL; Siegel D
    Am J Manag Care; 2001 Mar; 7(3):283-95. PubMed ID: 11258145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
    Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW
    Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
    Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.
    Simoons ML; Vos J; de Feyter PJ; Bots ML; Remme WJ; Grobbee DE; Kluft C; de Maat MP; Fox KM; Deckers JW
    Eur Heart J; 1998 Sep; 19 Suppl J():J56-60. PubMed ID: 9796842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of IgA nephropathy: an update.
    Rosselli JL; Thacker SM; Karpinski JP; Petkewicz KA
    Ann Pharmacother; 2011 Oct; 45(10):1284-96. PubMed ID: 21954446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BANFF: an update.
    Anderson T
    Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.